Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 123 Records) |
Query Trace: ELN[original query] |
---|
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation. Blood cancer journal 2022 12 12 (12): 170. Jentzsch Madlen, Bischof Lara, Ussmann Jule, Backhaus Donata, Brauer Dominic, Metzeler Klaus H, Merz Maximilian, Vucinic Vladan, Franke Georg-Nikolaus, Herling Marco, Platzbecker Uwe, Schwind Sebasti |
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients. Frontiers in oncology 2022 12 12 1054458. Villar Sara, Ariceta Beñat, Agirre Xabier, Urribarri Aura Daniela, Ayala Rosa, Martínez-Cuadrón David, Bergua Juan Miguel, Vives Susana, Algarra Lorenzo, Tormo Mar, Martínez Pilar, Serrano Josefina, Simoes Catia, Herrera Pilar, Calasanz Maria José, Alfonso-Piérola Ana, Paiva Bruno, Martínez-López Joaquín, San Miguel Jesús F, Prósper Felipe, Montesinos P |
Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia. Cancer medicine 2022 11 . Calleja Anne, Loschi Michael, Bailly Laurent, Morisot Adeline, Marceau Alice, Mannone Lionel, Robert Guillaume, Auberger Patrick, Preudhomme Claude, Raynaud Sophie, Subtil Fabien, Sujobert Pierre, Cluzeau Thom |
Association of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia. Cancer reports (Hoboken, N.J.) 2022 11 e1746. Shultz Carl, Gates Christopher, Petros William, Ross Kelly, Veltri Laruen, Craig Michael, Wen Sijin, Primerano Donald A, Hazlehurst Lori, Denvir James, Sdrimas Konstantin |
Genetical Signature-An Example of a Personalized Skin Aging Investigation with Possible Implementation in Clinical Practice. Journal of personalized medicine 2023 9 13 (9): . Ramune Sepetiene, Vaiva Patamsyte, Paulius Valiukevicius, Emilija Gecyte, Vilius Skipskis, Dovydas Gecys, Zita Stanioniene, Svajunas Barakausk |
AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts. Leukemia research 2023 9 134 107376. Davidson Zhao, Qianghua Zhou, Mojgan Zarif, Entsar Eladl, Cuihong Wei, Eshetu G Atenafu, Andre Schuh, Anne Tierens, Yu Wing Tony Yeung, Mark D Minden, Hong Cha |
TP53 status and impact on AML prognosis within the ELN 2022 risk classification. Blood 2023 8 . Shaun A Fleming, Xavier Cheng-Hong Tsai, Rhiannon Morris, Hsin-An Hou, Andrew H W |
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification. Leukemia 2023 7 . Michael J Hochman, Megan Othus, Robert P Hasserjian, Alex Ambinder, Andrew Brunner, Mary-Elizabeth M Percival, Christopher S Hourigan, Ronan Swords, Amy E DeZern, Elihu H Estey, Judith E Ka |
Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome. British journal of haematology 2023 7 . Friederike Pastore, Hanna Gittinger, Susanne Raab, Sebastian Tschuri, Bianka Ksienzyk, Nikola P Konstandin, Stephanie Schneider, Maja Rothenberg-Thurley, Hans-Peter Horny, Martin Werner, Maria C Sauerland, Susanne Amler, Dennis Görlich, Wolfgang E Berdel, Bernhard Wörmann, Jan Braess, Wolfgang Hiddemann, Johanna Tischer, Tobias Herold, Klaus H Metzeler, Karsten Spiekerma |
Outstanding Characteristics of Birt-Hogg-Dube Syndrome in Korea. Diagnostics (Basel, Switzerland) 2023 6 13 (12): . Hye Jung Park, Yong Jun Choi, Chul Hwan Park, Tae Hoon Kim, Sung Soo Lee, Duk Hwan Moon, Kyung-A Lee, Sang Eun Lee, Moo Suk Park, Song Yee Kim, Yoon Soo Chang, Seok Jeong Lee, Ji Ye Jung, Ji-Ho Lee, Su Hwan Lee, Taehee Kim, Sung-Ryeol Kim, Kangjoon Kim, Min Kwang By |
Cytogenetically Normal Acute Myeloid Leukaemia at a Single Centre in South Africa. Hematology/oncology and stem cell therapy 2023 6 16 (4): 397-406. Nicholas Jenkins, Lee-Ann Blanshard, Marian Stone, Estelle Verburgh, Jenna Oosthuizen, Karen Shir |
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia. Blood advances 2023 5 . Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Zoe S Stone-Molloy, Jordan Chervin, Brian J Ball, Zachary D Epstein-Peterson, Maria E Arcila, Aaron J Stonestrom, Andrew Dunbar, Sheng F Cai, Jacob L Glass, Mark B Geyer, Raajit K Rampal, Ellin Berman, Omar I Abdel-Wahab, Eytan M Stein, Martin S Tallman, Ross L Levine, Aaron D Goldberg, Elli Papaemmanuil, Yanming Zhang, Mikhail Roshal, Andriy Derkach, Wenbin Xi |
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 2023 5 13 (1): 77. Claudia Sargas, Rosa Ayala, María J Larráyoz, María C Chillón, Eduardo Rodriguez-Arboli, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan Bergua, Lorenzo Algarra, Mar Tormo, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan M Alonso-Dominguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María J Calasanz, Ramón García-Sanz, José A Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, |
Somatic exonic deletions in RUNX1 constitutes a novel recurrent genomic abnormality in acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Eriksson Anna, Engvall Marie, Mathot Lucy, Österroos Albin, Rippin Martin, Cavelier Lucia, Ladenvall Claes, Baliakas Panagiot |
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia. Leukemia 2023 4 . Nicolas Duployez, Loïc Vasseur, Rathana Kim, Laëtitia Largeaud, Marie Passet, Anaïs L'Haridon, Pierre Lemaire, Laurène Fenwarth, Sandrine Geffroy, Nathalie Helevaut, Karine Celli-Lebras, Lionel Adès, Delphine Lebon, Céline Berthon, Alice Marceau-Renaut, Meyling Cheok, Juliette Lambert, Christian Récher, Emmanuel Raffoux, Jean-Baptiste Micol, Arnaud Pigneux, Claude Gardin, Eric Delabesse, Jean Soulier, Mathilde Hunault, Hervé Dombret, Raphael Itzykson, Emmanuelle Clappier, Claude Preudhom |
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia. Leukemia 2023 4 . Rausch Christian, Rothenberg-Thurley Maja, Dufour Annika, Schneider Stephanie, Gittinger Hanna, Sauerland Cristina, Görlich Dennis, Krug Utz, Berdel Wolfgang E, Woermann Bernhard J, Hiddemann Wolfgang, Braess Jan, von Bergwelt-Baildon Michael, Spiekermann Karsten, Herold Tobias, Metzeler Klaus |
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia 2023 2 . Mrózek Krzysztof, Kohlschmidt Jessica, Blachly James S, Nicolet Deedra, Carroll Andrew J, Archer Kellie J, Mims Alice S, Larkin Karilyn T, Orwick Shelley, Oakes Christopher C, Kolitz Jonathan E, Powell Bayard L, Blum William G, Marcucci Guido, Baer Maria R, Uy Geoffrey L, Stock Wendy, Byrd John C, Eisfeld Ann-Kathr |
Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia. Frontiers in oncology 2023 12 13 1302356. Peng Ke, Jundan Xie, Ting Xu, Meiyu Chen, Yusha Guo, Ying Wang, Huiying Qiu, Depei Wu, Zhao Zeng, Suning Chen, Xiebing B |
Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia. Hematology (Amsterdam, Netherlands) 2023 12 29 (1): 2293512. Jingying Cui, Xuexing Chen, Chunfang Li, Qiong Yan, Guolin Yu |
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients. American journal of hematology 2023 12 . Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Antoine N Saliba, Mehrdad Hefazi Torghabeh, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Talha Badar, Hemant Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Arana Yi, Ayalew Teffe |
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial. Nature cancer 2023 10 . Nora Liebers, Peter-Martin Bruch, Tobias Terzer, Miguel Hernandez-Hernandez, Nagarajan Paramasivam, Donnacha Fitzgerald, Heidi Altmann, Tobias Roider, Carolin Kolb, Mareike Knoll, Angela Lenze, Uwe Platzbecker, Christoph Röllig, Claudia Baldus, Hubert Serve, Martin Bornhäuser, Daniel Hübschmann, Carsten Müller-Tidow, Friedrich Stölzel, Wolfgang Huber, Axel Benner, Thorsten Zenz, Junyan Lu, Sascha Dietri |
The trace that is valuable: serum copper and copper to zinc ratio for survival prediction in younger patients with newly diagnosed acute myeloid leukaemia. BMC cancer 2023 1 23 (1): 14. Li Taotao, Shi Liming, Wei Wei, Xu Jiancheng, Liu Qiu |
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO precision oncology 2023 1 7 e2200400. Cantu Miguel D, Kanagal-Shamanna Rashmi, Wang Sa A, Kadia Tapan, Bueso-Ramos Carlos E, Patel Sanjay S, Geyer Julia T, Tam Wayne, Madanat Yazan, Li Peng, George Tracy I, Nichols Meredith M, Rogers Heesun J, Liu Yen-Chun, Aggarwal Nidhi, Kurzer Jason H, Maracaja Danielle L V, Hsi Eric D, Zaiem Feras, Babu Daniel, Foucar Kathryn, Laczko Dorottya, Bagg Adam, Orazi Attilio, Arber Daniel A, Hasserjian Robert P, Weinberg Olga |
High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk. Clinical and experimental medicine 2023 1 . Xu Nan, Chen Wen-Min, Li Ling-Di, Long Ling-Yu, Wang Xu, Jiang Qian, Jiang Hao, Huang Xiao-Jun, Qin Ya-Zh |
CD7-positive leukemic blasts with DNMT3A mutations predict poor prognosis in patients with acute myeloid leukemia. Frontiers in oncology 2024 4 14 1342998. Yanliang Bai, Xiaobai Sun, Mengyi Li, Xiaona Niu, Weijie Cao, Junwei Niu, Xingjun Xiao, Yuqing Chen, Kai S |
Treatment outcome and germline predictive factors of ropeginterferon alpha-2b in myeloproliferative neoplasm patients. Cancer medicine 2024 4 13 (7): e7166. Chih-Cheng Chen, Ming-Chung Kuo, Ying-Hsuan Wang, Sung-Nan Pei, Ming-Lih Huang, Chiu-Chen Chen, Cih-En Huang, Yi-Yang Chen, Lee-Yung Sh |
A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia. Annals of hematology 2024 1 . Juanjuan Song, Weiya Li, Yanliang Bai, Pan Zhou, Junwei Niu, Xiaona Niu, Ying Liu, Xiaobo Liu, Emmanuel Kwateng Drokow, Kai Sun, Hu Zh |
Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India. Journal of hematopathology 2024 1 16 (1): 17-25. Neha Singh, Avinash Gupta, Sujeet Kumar, Gojiri Mawalankar, Bhumika Gupta, Nilesh Dhole, RohitKumar Kori, Anil Sin |
Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML. Blood advances 2024 1 . Onyee Chan, Najla H Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad O Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison R Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra L Sweet, Rami S Komrokji, Jeffrey E Lanc |
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 2024 1 14 (1): 15. Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor-Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Ti |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: